On Thursday 24th September, Dr James Routh, and other members of the Executive Leadership Team and Senior Leaders hosted a Capital Markets Event in London. The event provided insights into our differentiated value proposition, the progress made to improve performance, and our strategy to deliver sustainable long-term value for shareholders.
“We are transforming the culture and operating model to unlock our potential and drive significant growth in profit and cash generation over the medium term. We are already delivering results and have a clear path to sustainable shareholder value creation.”Dr James Routh
Chief Executive Officer
Sets out the Victrex investment proposition: leadership in growth markets, compelling competitive advantages and a performance-focused culture. Supported by a simpler operating model and a clear strategy to drive profitable growth and create shareholder value.
Provides detail on Victrex Performance Materials’ strong foundations, untapped potential, and strategic priorities to deliver profitable revenue growth and optimise global operations.
Shares plans to unlock the potential within our medical business, building on core strengths and growing through stronger commercial execution, while optimising the organisation.
Describes our operational transformation programme, including the actions we are taking to drive improved performance.
Our premium offering, combining deep PEEK expertise, application engineering and differentiated manufacturing – always operating as a trusted solutions partner to deliver added value for our customers.
Our partnership with Ensigner is helping them solve complex challenges across sectors and create new markets.
Ensinger customer testimonial
Our partnership with Daher is delivering proven performance aerospace customers can rely on.
Daher customer testimonial
Our partnership with Aesculap is using PEEK technology to deliver a new standard in implant replacement.
Aesculap customer testimonial